Possibility of using dabigatran in patients with atrial fibrillation and acute coronary syndrome and PCI

This article is devoted to the problem of combined antithrombotic therapy in patients with atrial fibrillation (AF) undergoing percutaneous coronary intervention (PCI) due to acute coronary syndrome (ACS). Traditionally, these patients require an oral anticoagulant (OAC) to prevent stroke and dual a...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autor: A. D. Erlich
Format: Artigo
Jezik:Russo
Izdano: Remedium Group LLC 2019-04-01
Serija:Медицинский совет
Teme:
atrial fibrillation
acute coronary syndrome
pci
anticoagulant
dabigatran
Online pristup:https://www.med-sovet.pro/jour/article/view/2911
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items